β2-Adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms

Archives of Biochemistry and Biophysics

Volumn 482, Issue 1-2, 2009, Pages 96-103

  Aitken, Sarah J ^a   Landao Bassonga, Euphemie ^a   Ralston, Stuart H ^a   Idris, Aymen I ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adrenoceptors; Bone; Catecholamine; Isoprenaline; Noradrenaline; Osteoblast; Osteoclast

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; COLONY STIMULATING FACTOR 1; ISOPRENALINE; NORADRENALIN; OSTEOCLAST DIFFERENTIATION FACTOR; SALMETEROL; CALCITRIOL; COMPLEMENTARY DNA; RNA;

ANIMAL CELL; ARTICLE; BONE CELL; BONE DENSITY; BONE MASS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BONE DEVELOPMENT; BONE MARROW CELL; COCULTURE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; NEWBORN; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; BONE DEVELOPMENT; BONE MARROW CELLS; CALCITRIOL; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DNA, COMPLEMENTARY; GENE EXPRESSION; ISOPROTERENOL; MICE; NOREPINEPHRINE; OSTEOCLASTS; POLYMERASE CHAIN REACTION; RANK LIGAND; RECEPTORS, ADRENERGIC, BETA-2; RNA;

EID: 58849161716     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2008.11.012     Document Type: Article

References (13)

1. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W.G., Bannon T.W., Noda M., Clement K., Vaisse C., and Karsenty G. Nature 434 (2005) 514-520
2. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., Armstrong D., Ducy P., and Karsenty G. Cell 111 (2002) 305-317
3. Cherruau M., Facchinetti P., Baroukh B., and Saffar J.L. Bone 25 (1999) 545-551
4. Bonnet N., Laroche N., Vico L., Dolleans E., Benhamou C.L., and Courteix D. J. Pharmacol. Exp. Ther. 318 (2006) 1118-1127
5. Minkowitz B., Boskey A.L., Lane J.M., Pearlman H.S., and Vigorita V.J. J. Orthop. Res. 9 (1991) 869-875
6. Bonnet N., Benhamou C.L., Brunet-Imbault B., Arlettaz A., Horcajada M.N., Richard O., Vico L., Collomp K., and Courteix D. Bone 37 (2005) 622-633
7. de V.F., Pouwels S., Bracke M., Leufkens H.G., Cooper C., Lammers J.W., and van Staa T.P. Pharmacoepidemiol. Drug Saf. 16 (2007) 612-619
8. Reid I.R., Gamble G.D., Grey A.B., Black D.M., Ensrud K.E., Browner W.S., and Bauer D.C. J. Bone Miner. Res. 20 (2005) 613-618
9. Idris A.I., Sophocleous A., Landao-Bassonga E., van't Hof R.J., and Ralston S.H. Endocrinology 149 (2008) 5619-5626
10. Idris A.I., Van 't Hof R.J., Greig I.R., Ridge S.A., Baker D., Ross R.A., and Ralston S.H. Nat. Med. 11 (2005) 774-779
11. Idris A.I., Rojas J., Greig I.R., van't Hof R.J., and Ralston S.H. Calcif. Tissue Int. 82 (2008) 191-201
12. Stewart T.L., Roschger P., Misof B.M., Mann V., Fratzl P., Klaushofer K., Aspden R.M., and Ralston S.H. Calcif. Tissue. Int. 77 (2005) 113-118
13. Serre C.M., Farlay D., Delmas P.D., and Chenu C. Bone 25 (1999) 623-629